SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

9.55
Delayed Data
As of Jul 27
 -0.12 / -1.24%
Today’s Change
4.74
Today|||52-Week Range
11.71
+9.02%
Year-to-Date

Today’s Trading

Previous close9.67
Today’s open9.62
Day’s range-- - --
Volume378,510
Average volume (3 months)515,129
Market cap$479.7M
Dividend yield--
Data as of 07/27/2015

Growth & Valuation

Earnings growth (last year)+140.00%
Earnings growth (this year)+20.83%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+6.09%
P/E ratio16.7
Price/Sales3.42
Price/Book3.11

Competitors

 Today’s
change
Today’s
% change
ADMSAdamas Pharmaceutica...-0.65-2.43%
AFMDAffimed NV-0.04-0.25%
RGLSRegulus Therapeutics...-0.49-5.34%
CARACara Therapeutics In...-0.65-3.18%
Data as of 07/27/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$0.13
Annual revenue (last year)$134.8M
Annual profit (last year)$25.2M
Net profit margin18.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Friedhelm Blobel
Chief Financial Officer &
Senior Vice President
Wai-Shun Wilson Cheung
Corporate headquarters
Foster City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers